Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"Glucosides"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Glucosides%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Glucosides%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Glucosides%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (33)
1
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes : Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Frías, J.
|
Maaske, J.
|
Suchower, L.
| +4
Wird geladen...
2
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes : A post hoc analysis of pooled data from four phase 3 randomized clinical trials
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Lund, S.
|
Sattar, N.
|
Salsali, A.
| +2
Wird geladen...
3
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes : A randomized, parallel-design, open-label, Phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Vilsbøll, T.
|
Ekholm, E.
|
Johnsson, E.
| +4
Wird geladen...
4
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5) : 52-week results from a randomized, open-label, phase III clinical trial
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Araki, E.
|
Watada, H.
|
Uchigata, Y.
| +9
Wird geladen...
5
Basal insulin secretion capacity predicts the initial response and maximum levels of beta-hydroxybutyrate during therapy with the sodium-glucose co-transporter-2 inhibitor tofogliflozin, in relation to weight loss
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Sato, Y.
|
Nunoi, K.
|
Kaku, K.
| +2
Wird geladen...
6
Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus : A randomized, double-blind, phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Kaku, K.
|
Isaka, H.
|
Sakatani, T.
| +1
Wird geladen...
7
Renal effects of a sodium-glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Nunoi, K.
|
Sato, Y.
|
Kaku, K.
| +2
Wird geladen...
8
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Handelsman, Y.
|
Mathieu, C.
|
Del Prato, S.
| +5
Wird geladen...
9
Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes : Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Kaku, K.
|
Haneda, M.
|
Tanaka, Y.
| +7
Wird geladen...
10
Empagliflozin compared with glimepiride in metformin-treated patients with type 2 diabetes : 208-week data from a masked randomized controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Ridderstråle, M.
|
Rosenstock, J.
|
Andersen, K.
| +3
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: Glucosides
Medienart
33
Aufsätze
33
E-Artikel
33
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
33
Clinical Trial, Phase III
Glucosides
33
Journal Article
33
Randomized Controlled Trial
29
Research Support, Non-U.S. Gov't
26
Benzhydryl Compounds
26
Hypoglycemic Agents
23
Blood Glucose
23
Multicenter Study
22
Glycated Hemoglobin A
18
9100L32L2N
18
Metformin
17
type 2 diabetes
16
1ULL0QJ8UC
16
SGLT2 inhibitor
16
dapagliflozin
13
hemoglobin A1c protein, human
10
phase III study
9
Sodium-Glucose Transporter 2 Inhibitors
8
HDC1R2M35U
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2020-
28
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
33
Englisch
Haven't found what you're looking for?
Wird geladen...